Want to see IN:GRANULES full AI Analyst Report?
GRANULES Stock Chart & Stats
₹615.10
₹1.80(0.30%)
At close: 4:00 PM EST
₹615.10
₹1.80(0.30%)
Day’s Range― - ―
52-Week Range₹433.00 - ₹910.00
Previous CloseN/A
Volume528.44K
Average Volume (3M)56.05K
Market Cap
₹223.80B
Enterprise Value₹157.75K
Total Cash (Recent Filing)₹6.26B
Total Debt (Recent Filing)₹18.07B
Price to Earnings (P/E)36.0
Beta0.84
Next Earnings
Jul 21, 2026EPS Estimate
7.7Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)21.14
Shares Outstanding247,796,920
10 Day Avg. Volume60,875
30 Day Avg. Volume56,048
Financial Highlights & Ratios
PEG Ratio1.39
Price to Book (P/B)2.97
Price to Sales (P/S)2.81
P/FCF Ratio125.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)32.03
Revenue Forecast (FY)₹62.31B
Bulls Say, Bears Say
Bulls Say
Vertical Integration Across API, PFI And FDFOwning API, PFI and finished-dosage capabilities creates durable cost and supply advantages. Vertical integration supports margin preservation, reduces third-party dependency, and enables capture of value across the chain, strengthening long-term competitiveness and customer stickiness.
Manageable Leverage And Steady Balance SheetConservative debt levels for a manufacturing business reduce refinancing and liquidity risk, enabling sustained capital expenditure and capacity expansion. A stable balance sheet supports long-term contracts, investment in compliance, and resilience through industry cycles.
Revenue Growth Resumed In FY2026A return to top-line growth after stagnation signals recovered demand or successful market execution. Sustained revenue momentum supports scale economies and absorption of fixed costs, increasing the durability of operating margins if maintained over coming quarters.
Bears Say
Gross Profit Fell Despite Higher RevenueFalling gross profit amid revenue growth indicates cost pressures or pricing erosion. This undermines operating leverage and can compress long-term margins if structural (raw material inflation, mix shift, or pricing competition), reducing earnings durability unless cost control or pricing power improves.
Uneven Cash Conversion And Weaker Free Cash FlowVolatile free cash flow versus reported earnings signals working-capital swings or heavy capex needs. Inconsistent cash conversion limits the company’s ability to fund growth, pay down debt, or return capital, raising execution risk and making investment plans harder to rely on long term.
Return On Equity Has Trended LowerDeclining ROE means incremental capital is generating lower returns, pointing to weaker profitability or less efficient deployment. Persistently lower ROE can constrain shareholder value creation and signal increased competition, price pressure, or diminishing operating efficiency over time.
Granules India Limited News
GRANULES FAQ
What was Granules India Limited’s price range in the past 12 months?
Granules India Limited lowest stock price was ₹433.00 and its highest was ₹910.00 in the past 12 months.
What is Granules India Limited’s market cap?
Granules India Limited’s market cap is ₹223.80B.
When is Granules India Limited’s upcoming earnings report date?
Granules India Limited’s upcoming earnings report date is Jul 21, 2026 which is in 2 days.
How were Granules India Limited’s earnings last quarter?
Granules India Limited released its earnings results on Apr 29, 2026. The company reported ₹7.55 earnings per share for the quarter, beating the consensus estimate of ₹6.05 by ₹1.5.
Is Granules India Limited overvalued?
According to Wall Street analysts Granules India Limited’s price is currently Overvalued.
Does Granules India Limited pay dividends?
Granules India Limited pays a Annually dividend of ₹1.75 which represents an annual dividend yield of 0.24%. See more information on Granules India Limited dividends here
What is Granules India Limited’s EPS estimate?
Granules India Limited’s EPS estimate is 7.7.
How many shares outstanding does Granules India Limited have?
Granules India Limited has 247,796,920 shares outstanding.
What happened to Granules India Limited’s price movement after its last earnings report?
Granules India Limited reported an EPS of ₹7.55 in its last earnings report, beating expectations of ₹6.05. Following the earnings report the stock price went up 0.078%.
Which hedge fund is a major shareholder of Granules India Limited?
Currently, no hedge funds are holding shares in IN:GRANULES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Granules India Limited
Founded in 1984 and headquartered in Hyderabad, India, Granules India Limited operates as a key player in the pharmaceutical sector. The company is engaged in the manufacturing and global distribution of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs), intermediate compounds for drug formulation, and final dosage forms (FDFs). Its API portfolio addresses various therapeutic categories, such as antiviral medications, treatments for hypertension, antihistamines, anti-infectives, pain relief agents, anticoagulants, anti-fibrinolytic drugs, and platelet inhibitors. Additionally, Granules produces a variety of FDFs, encompassing tablets, caplets, and press-fit capsules, which are supplied in bulk, blister packs, and bottles. The firm also develops specialized products for oncology. Granules India Limited maintains a broad international presence, with its products reaching markets across India, North America, Europe, Latin America, Africa, and the Middle East.
Technical Analysis
Aurobindo Pharma Ltd
―
Glenmark Life Sciences Limited
―
Jubilant Pharmova Limited
―
Laurus Labs Ltd.
―
Neuland Laboratories Ltd.
―